Back

Aspirin has a remaining role in the prevention and treatment of cardiovascular disease: con.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Great Debate: time to say goodbye to aspirin in cardiovascular disease prevention? Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
Aspirin has a remaining role in the prevention and treatment of cardiovascular disease: pro.
Doctor C. Aguiar (Lisbon, PT)
Slides Video
Presentation thumbnail
Time to say goodbye to aspirin in cardiovascular disease prevention? – the final word.
Video

Access the full session

Session thumbnail
Great Debate: time to say goodbye to aspirin in cardiovascular disease prevention?
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Aspirin does not reduce cardiovascular risk in smokers across coronary calcium scores after coronary computed tomography angiography
thumbnail
Congress Presentation
Aspirin does not not associate with lower risk of major cardiovascular events or increased risk of bleeding in older individuals undergoing cardiac computed tomography angiography

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources